CNTX
Context Therapeutics Inc
NASDAQ: CNTX · HEALTHCARE · BIOTECHNOLOGY
$2.34
-6.77% today
Updated 2026-04-29
Market cap
$207.65M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$0 – $4
Volume
0.9M
Context Therapeutics Inc (CNTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-30.57M | $-22.35M | $-2.84M | $-1.03M | $-8.80M | $-13.55M | $-21.05M | $-14.56M | $-26.39M |
| Capital expenditures | $28000.00 | $28000.00 | $0.00 | $0.00 | $250000.00 | $536836.00 | $0.00 | $14.76M | $33948.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $775255.00 | $219245.00 | $511079.00 | $976440.00 | $1.08M | $841867.00 | $1.33M |
| Free cash flow | $-30.60M | $-22.38M | $-2.84M | $-1.03M | $-9.05M | $-14.09M | $-21.05M | $-29.31M | $-26.42M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — |